Skip to main content
. 2021 Feb 18;10:616440. doi: 10.3389/fonc.2020.616440

Figure 3.

Figure 3

Optimization and validation of Plectin-1 in healthy controls. To validate the specificity of Plectin-1 antigen in detecting circulating tumor cells (CTCs), the number of CTCs was counted in peripheral blood samples of eighteen healthy volunteers after immunostaining with anti-Plectin-1 and anti-CD45 antibody. Plectin-1+CD45-DAPI+ CTC counts per 1 ml blood were calculated individually.